Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 118 results for "biocon"

Biocon's breast cancer biosimilar gets USFDA panel nod
Money Today

Biocon cancer drug now only a step away from getting USFDA app...

Biocon is one step away from securing the Food and Drug Administration approval for its first biologic drug in the US. On Thursday, the FDA's Oncologic Drug Advisory Committee recommended approval of Biocon's proposed biosimilar Trastuzumab which is indicated ... Business Standard, 1 week ago

78 images for biocon

Money Control, 6 days ago
Money Control, 6 days ago
Money Today, 1 week ago
Money Control, 1 week ago
Sify, 1 week ago
Money Control, 1 week ago
Money Control, 1 week ago
Money Control, 1 week ago
Money Control, 1 week ago
Money Control, 1 week ago

BUZZ-FDA panel okays Mylan, Biocon's copy of Roche's Herceptin

(Updates) ** Generic drugmaker's shares up about 2 pct at$39.80 in light premarket trading ** Advisory committee to FDA unanimously recommends approvalfor its biosimilar ** Oncologic Drugs Advisory Committee votes 16-0 in supportof MYL's and Biocon Ltd's ...
 Sify1 week ago BUZZ-India's Biocon surges; U.S. FDA committee recommends approval of drug  Sify1 week ago Biocon surges; US FDA committee recommends approval of drug  Sify1 week ago
Money Control

Setback for Biocon's European biosimilar plans

French regulator's observations about the formulation facilities will delay product launches
 Business Standard1 week ago Biocon cracks over 9% as French regulator finds lapses at Bengaluru plant  Money Control2 weeks ago French regulator finds GMP violations at Biocon#39;s Bengaluru plant  Money Control2 weeks ago

Will try ask for re-inspection at the earliest, says Biocon

There appears to be a setback for Biocon as its biosimilars program hits a roadblock in Europe -- the drug products unit inspection done in March has not received the GMP certificate by the French regulator. In an interview to CNBC-TV18, Kiran Mazumdar Shaw, ...
 Money Control2 weeks ago Biocon receives GMP compliance certificates for two facilities in Bangalore  Business Standard2 weeks ago ANSM gives GMP nod to Biocon, to re-inspect drug product unit  DNA2 weeks ago

Hindustan Unilever, Maruti Suzuki, ACC, Power Grid hit new highs

Adani Ports, Biocon, Birla Corp, Dalima Bharat and Future Consumer too hit record highs
 Business Standard5 days ago

Biocon hits record high after US FDA approves new breast cancer drug

The stock surged 10% to Rs 404 on BSE in early morning trade on back of heavy volumes.
 Business Standard1 week ago Biocon surges 11% ahead of USFDA meet for new drug filing  Business Standard1 week ago Biocon hits record high  Business Standard1 week ago Biocon hits three-month low on USFDA observation for Bengaluru facility  Business Standard2 months ago

ODAC’s approval takes us one step closer to USFDA nod for trastuzumab: Biocon’s CMD

The United States Foods and Drug Administration (USFDA) Oncologic Drugs Advisory Committee (ODAC) has recommended an approval of a biosimilar trastuzumab in the US. Trastuzumab is Biocon and Mylan#39;s biosimilar which is a biosimilar version of Herceptin ...
 Money Control1 week ago ODAC recommends approval for Mylan and Biocon's proposed biosimilar trastuzumab  Business Standard1 week ago
Money Control

Biocon tumbles on observations by French health regulator

Biocon fell 5.09% to Rs 319.90 at 11:42 IST on BSE on reports that the French health regulator found lapses in quality compliance at its Bangalore plant during a March inspection.
 Business Standard1 week ago Biocon shares dip 4% on USFDA observations  Business Standard2 months ago Biocon slips after USFDA observations  Business Standard2 months ago Received observations from USFDA, responded to all: Biocon  DNA2 months ago
Money Control

Stocks in the news: Tata Motors, Cadila, Fortis, Biocon, IDFC, Satin Credit, RCF, Gati

Tata Motors | Cadila Healthcare | Tata Power | Fortis Healthcare | Biocon | SCI | IDFC | Pokarna | Satin Creditcare | Chambal Fertiliser | NFL | GSFC | GNFC | RCF | Bhushan Steel | Tata Teleservices | Reliance Communications and Gati are stocks, which are in ...
 Money Control2 weeks ago Cadila Healthcare, Jubilant and Biocon are able to grow despite pressures  Business Standard3 weeks ago
Money Today

Biocon to address French regulator concerns in a quarter: Mazumdar Shaw

Kiran Mazumdar Shaw, chairman and managing director of Biocon says that India's largest Biopharma company will take remedial measures at its drug product facility within a quarter and ask the French medical regulator to inspect its facility again to get ...
 Business Standard1 week ago Mazumdar-Shaw appointed to Board of Live Love Laugh Foundation  Business Standard1 month ago EXCLUSIVE: Biocon open to ‘unlocking value’ in units after 5 years; may look at MA  Money Control2 months ago Biocon's adjusted Q4 net profit up; company issues bonus shares  Money Today2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less